Abstract:Objective: To analyze the use of blood products in patients at different ages. Methods: The clinical datas of the 10 784 patients transfused in Sichuan provincial people's hospital at 2017-2018 were retrospectively analyzed, and the basic condition of clinical blood using was statistically described. The patients were divided into the groups according to age and disease, then the use of various blood products in the patients with different diseases in different age groups was analyzed. Results: The age of blood transfusion patients was mainly 40-80 years old, and the most common disease was tumor(about 28%). The average annual transfusion volumes of red blood cells(RBC) were 24 936.5 U, of platelets(PLT) were 3 795 therapeutic doses of plasma were 2 455 500 ml, of cryoprecipitate were 3 461.5 U in our hospital. Most patients with hematologic malignancies and liver cirrhosis were transfused with two or more blood productions. For the patients with hematologic malignancies, the irradiated RBC (76.4%), PLT (67.8%), and suspended RBC (59.9%) were commonly used. And for liver cirrhosis patients, the suspended RBC (64.2%) and fresh frozen plasma(FFP) (59.4%) were commonly used. For the patients with trauma and chronic kidney disease(CKD), the suspended RBC (95.7% and 91.5%, respectively) was commonly used. In hematologic malignancies patients, the transfusion volume of irradiated RBC, PLT and FFP in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05); in trauma patients, the transfusion volume of suspended RBC in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05). In hematologic malignancies, trauma and liver cirrhosis patients, the proportion of PLT and/or plasma transfusion in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05), and the elderly patients were more likely to receive RBC transfusion only. Conclusion: There is a difference in the distribution of blood product between the patients aged<60 years old and ≥60 years old in the same disease, and it is more likely that the elderly patients (aged ≥60 years old) receive RBC transfusion only, and correction of hypoxia is a major clinical consideration, so blood using plans should be made according to the patient population, moreover, the different transfusion strategies should be developed for different population to maximize the efficiency of blood using.

Analysis of blood transfusion for patients with brain tumor in perioperative period

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

Analysis of clinical blood transfusion and transfusion-related factors for patients with lung cancer during perioperative period

A retrospective study of blood transfusion In 18 310 abdominal tumor surgical cases, from 1996 to 2007

A retrospective clinical analysis of intraoperative autologous blood transfusion about patients in the department of neurosurgery

[Clinical Blood Utilization of Patients at Different Ages for a Hospital in Sichuan from 2017 to 2018]

Clinical Analysis of the Application of Autologous Blood Transfusion in Neurosurgery of Primary Hospital

Relationship of perioperative blood transfusionwith clinicalprognosisin elderly hip fracture patients：analysis of 931 cases

Influence of Perioperative Blood Transfusion on Prognosis in Patients with Colon Cancer

Preoperative Immune Response is Associated with Perioperative Transfusion Requirements in Glioma Surgery

An investigation of blood transfusion rationality and early hemoglobin level in elderly patients undergoing hip replacement

Management of perioperative coagulation dysfunction in patients with massive blood transfusion during retroperitoneal tumor resection

Analysis of the formula of blood transfusion during cardiac surgery in our hospital

Temporal Trends and Geographic Variations in Perioperative Red Blood Cell Transfusion in Major Surgical Procedures from 2013 to 2018 in China.

Blood transfusion indications in neurosurgical patients: A systematic review

Thought on Blood Transfusion for Patients With Tumors

Retrospective analysis of perioperative blood transfusion in 49 117 cases of pediatric surgery

Red blood cell transfusion in neurosurgery

A comprehensive assessment of perioperative blood transfusion in liver transplantation

Trend analysis of clinical use of blood in 457 patients with cardiac surgery

Neutrophil–lymphocyte Ratio and Intraoperative Blood Transfusion: Independent Prognostic Factors of Elderly Patients with Oral Account